Gifts in Wills fund one-third of Cancer Research UK’s work. Work that supports life-saving trials for people like Alfred.

Latham-based medical technology company AngioDynamics is ramping up marketing of its NanoKnife cancer treatment machine after receiving approval from the U.S. Food and Drug Administration for its use ...

Vir Biotechnology announced promising results Wednesday for a pair of cancer treatments, and Vir stock catapulted by double ...

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of ...

AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, ...

Francis Medical Inc., a Twin Cities med-tech manufacturer that's developing a way to treat prostrate and other cancers with water vapor, said Tuesday it raised $80 million in its latest equity funding ...

A growing array of pharmaceutical options has investigators trying to figure out which drugs and drug combinations are the ...

New research from the IU School of Medicine found a discovery that could lead to new treatments for prostate cancer. The American Cancer Society said one in eight men will be ...

HRS-1167 is under clinical development by Merck and currently in Phase I for Castration-Resistant Prostate Cancer (CRPC).

Participation in the 340B Drug Pricing Program does not increase the use of targeted therapy in older patients with advanced prostate cancer, a study suggests.

The discovery could help explain why some cancer patients respond well to certain treatments, while others are not so lucky.